Zivo Bioscience Inc (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4 | 67 | 57 | 10 | 517 |
| Receivables | N/A | N/A | N/A | 34 | N/A |
| Inventories | 260 | 260 | N/A | N/A | N/A |
| TOTAL | $271 | $401 | $281 | $410 | $1,023 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 246 | 262 | 278 | 293 | 308 |
| TOTAL | $246 | $262 | $278 | $293 | $308 |
| Total Assets | $517 | $664 | $560 | $703 | $1,331 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,371 | 1,212 | 1,709 | 1,362 | 1,095 |
| Accrued Expenses | 1,758 | 2,522 | 1,685 | 66 | 1,290 |
| Other current liabilities | 40 | 40 | 15 | 34 | 29 |
| TOTAL | $3,758 | $4,209 | $3,614 | $2,960 | $2,613 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 12 | 47 | 82 |
| Other Non-Current Liabilities | 184 | 202 | 220 | 238 | 254 |
| TOTAL | $184 | $202 | $232 | $285 | $336 |
| Total Liabilities | $3,941 | $4,412 | $3,846 | $3,244 | $2,949 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,152 | 4,152 | 3,889 | 3,817 | 3,814 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -147,810 | -146,859 | -143,851 | -142,818 | -141,178 |
| TOTAL | $-3,425 | $-3,748 | $-3,287 | $-2,541 | $-1,617 |
| Total Liabilities And Equity | $517 | $664 | $560 | $703 | $1,331 |